Comparative effectiveness of radical cystectomy and radiotherapy without chemotherapy in frail patients with bladder cancer

References

• Witjes AJ, Lebret T, Compérat EM, et al. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2016;71:462–475.
   PubMed Web of Science ®Google Scholar
• Chang SS, Bochner BH, Chou R, et al. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline. J Urol. 2017;198(3):552–559.
   PubMed Web of Science ®Google Scholar
• D'Andrea D, Abufaraj M, Soria F, et al. Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization. World J Urol. 2019;71:462–468. 20
   Google Scholar
• Vetterlein MW, Klemm J, Gild P, et al. Improving estimates of perioperative morbidity after radical cystectomy using the European Association of Urology quality criteria for standardized reporting and introducing the comprehensive complication index. Eur Urol. 2019;77(1), 55–65.
   PubMed Web of Science ®Google Scholar
• Mak RH, Hunt D, Shipley WU, et al. Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233. J Clin Oncol. 2014;32(34):3801–3809.
   PubMed Web of Science ®Google Scholar
• Efstathiou JA, Spiegel DY, Shipley WU, et al. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. Eur Urol. 2012;61(4):705–711.
   PubMed Web of Science ®Google Scholar
• Booth CM, Siemens DR, Li G, et al. Curative therapy for bladder cancer in routine clinical practice: a population-based outcomes study. Clin Oncol (R Coll Radiol). 2014;26(8):506–514.
   PubMed Web of Science ®Google Scholar
• Shelley MD, Barber J, Wilt T, et al. Surgery versus radiotherapy for muscle invasive bladder cancer. Cochrane Database Syst Rev. 2002;54:CD002079.
   Google Scholar
• Chung PWM, Bristow RG, Milosevic MF, et al. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer. Urol Oncol. 2007;25(4):303–309.
   PubMed Web of Science ®Google Scholar
• Lutkenhaus LJ, van Os RM, Bel A, et al. Clinical results of conformal versus intensity-modulated radiotherapy using a focal simultaneous boost for muscle-invasive bladder cancer in elderly or medically unfit patients. Radiat Oncol. 2016;11(1):45.
   PubMedGoogle Scholar
• Kulkarni GS, Hermanns T, Wei Y, et al. Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic. J Clin Oncol. 2017;35(20):2299–2305. 10
   PubMed Web of Science ®Google Scholar
• Rink M, Fajkovic H, Cha EK, et al. Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol. 2012;61(4):854–855.
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Wang PS, Avorn J, et al. Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res. 2003;38(4):1103–1120.
   PubMed Web of Science ®Google Scholar
• Williams SB, Kamat AM, Chamie K, et al. Systematic review of comorbidity and competing-risks assessments for bladder cancer patients. Eur Urol Oncol. 2018;1(2):91–100.
   PubMed Web of Science ®Google Scholar
• Seisen T, Sun M, Lipsitz SR, et al. Comparative effectiveness of trimodal therapy versus radical cystectomy for localized muscle-invasive urothelial carcinoma of the bladder. Eur Urol. 2017;72(4):483–487.
   PubMed Web of Science ®Google Scholar
• Williams SB, Shan Y, Jazzar U, et al. Comparing survival outcomes and costs associated with radical cystectomy and trimodal therapy for older adults with muscle-invasive bladder cancer. JAMA Surg. 2018;27:1–9.
   Google Scholar
• Cahn DB, Handorf EA, Ghiraldi EM, et al. Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer. Cancer. 2017;9:551–559.
   Google Scholar
• Häggström C, Garmo H, de Luna X, et al. Survival after radiotherapy versus radical cystectomy for primary muscle‐invasive bladder cancer: a Swedish nationwide population‐based cohort study. Cancer Med. 2019;8(5):2196–2204.
   PubMed Web of Science ®Google Scholar
• James ND, Hussain SA, Hall E, et al. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med. 2012;366(16):1477–1488.
   PubMed Web of Science ®Google Scholar
• Mari A, D’Andrea D, Abufaraj M, et al. Genetic determinants for chemo- and radiotherapy resistance in bladder cancer. Transl Androl Urol. 2017;6(6):1081–1089.
   PubMed Web of Science ®Google Scholar
• Boström PJ, van Rhijn BWG, Fleshner N, et al. Staging and staging errors in bladder cancer. Eur Urol Suppl. 2010;9:2–9.
   Web of Science ®Google Scholar
• Shariat SF, Palapattu GS, Karakiewicz PI, et al. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol. 2007;51(1):137–149.
   PubMed Web of Science ®Google Scholar
• Moschini M, D'Andrea D, Korn S, et al. Characteristics and clinical significance of histological variants of bladder cancer. Nat Rev Urol. 2017;14(11):651–668.
   PubMed Web of Science ®Google Scholar
• >Bekelman JE, Handorf EA, Guzzo T, et al. Radical cystectomy versus bladder-preserving therapy for muscle-invasive urothelial carcinoma: examining confounding and misclassification biasin cancer observational comparative effectiveness research. Value Health. 2013;16(4):610–618.
   PubMed Web of Science ®Google Scholar